BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19899130)

  • 1. Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma.
    Kim HN; Kim NY; Yu L; Kim YK; Lee IK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ
    Am J Hematol; 2009 Dec; 84(12):821-5. PubMed ID: 19899130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults.
    Gemmati D; Ongaro A; Scapoli GL; Della Porta M; Tognazzo S; Serino ML; Di Bona E; Rodeghiero F; Gilli G; Reverberi R; Caruso A; Pasello M; Pellati A; De Mattei M
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):787-94. PubMed ID: 15159311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology.
    Kraggerud SM; Oldenburg J; Alnaes GI; Berg M; Kristensen VN; Fossa SD; Lothe RA
    Pharmacogenet Genomics; 2009 Oct; 19(10):751-9. PubMed ID: 19741569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
    Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
    Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma.
    Kim HN; Lee IK; Kim YK; Tran HT; Yang DH; Lee JJ; Shin MH; Park KS; Shin MG; Choi JS; Kim HJ
    Br J Haematol; 2008 Feb; 140(3):287-94. PubMed ID: 18042267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population.
    Alexandrie AK; Nyberg F; Warholm M; Rannug A
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):908-14. PubMed ID: 15184245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility.
    Yang M; Choi Y; Hwangbo B; Lee JS
    Lung Cancer; 2007 Aug; 57(2):135-42. PubMed ID: 17428572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer risk.
    Jourenkova-Mironova N; Voho A; Bouchardy C; Wikman H; Dayer P; Benhamou S; Hirvonen A
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):185-8. PubMed ID: 10067818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High order interactions of xenobiotic metabolizing genes and P53 codon 72 polymorphisms in acute leukemia.
    Chauhan PS; Ihsan R; Mishra AK; Yadav DS; Saluja S; Mittal V; Saxena S; Kapur S
    Environ Mol Mutagen; 2012 Oct; 53(8):619-30. PubMed ID: 22930568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors.
    Schwartzbaum JA; Ahlbom A; Lönn S; Warholm M; Rannug A; Auvinen A; Christensen HC; Henriksson R; Johansen C; Lindholm C; Malmer B; Salminen T; Schoemaker MJ; Swerdlow AJ; Feychting M
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):559-65. PubMed ID: 17372252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.
    Gra OA; Glotov AS; Nikitin EA; Glotov OS; Kuznetsova VE; Chudinov AV; Sudarikov AB; Nasedkina TV
    Am J Hematol; 2008 Apr; 83(4):279-87. PubMed ID: 18061941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
    Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
    Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: a population-based case-control study.
    Chiu BC; Kolar C; Gapstur SM; Lawson T; Anderson JR; Weisenburger DD
    Br J Haematol; 2005 Mar; 128(5):610-5. PubMed ID: 15725081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study.
    Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association with TP53 codon 72 polymorphism and the risk of non-Hodgkin lymphoma.
    Kim HN; Yu L; Kim NY; Lee IK; Kim YK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ
    Am J Hematol; 2010 Oct; 85(10):822-4. PubMed ID: 20734458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of drug-metabolizing enzymes CYP1A1, GSTT and GSTP contribute to the development of diffuse large B-cell lymphoma risk in the Saudi Arabian population.
    Al-Dayel F; Al-Rasheed M; Ibrahim M; Bu R; Bavi P; Abubaker J; Al-Jomah N; Mohamed GH; Moorji A; Uddin S; Siraj AK; Al-Kuraya K
    Leuk Lymphoma; 2008 Jan; 49(1):122-9. PubMed ID: 18203021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary glucosinolate intake, polymorphisms in selected biotransformation enzymes, and risk of prostate cancer.
    Steinbrecher A; Rohrmann S; Timofeeva M; Risch A; Jansen E; Linseisen J
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):135-43. PubMed ID: 20056632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.
    Miller DP; Liu G; De Vivo I; Lynch TJ; Wain JC; Su L; Christiani DC
    Cancer Res; 2002 May; 62(10):2819-23. PubMed ID: 12019159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.